论文信息 - Gemcitabine in models of acute and accelerated rejection. - 字舞流文

Gemcitabine in models of acute and accelerated rejection.

H. Grimm | S. Wilker | S. Korom | M. Brendel | E. Maas | F. Jung

[1] R. Margreiter,et al. Gemcitabine--a novel immunosuppressive agent--prevents rejection in a rat cardiac transplantation model. , 1999, Transplantation.

[2] J. Kupiec-Weglinski,et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. , 1997, Transplantation.

[3] S. Kaye. Gemcitabine: current status of phase I and II trials. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.